acetylcysteine has been researched along with byl719 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auf der Maur, P; Baumann, Z; Bentires-Alj, M; Buczak, K; Correia, AL; Diepenbruck, M; Eichlisberger, T; Fritsch, C; Jensen, MR; Kramer, N; Leroy, C; Okamoto, R; Preca, BT; Rad, R; Ramos, P; Stadler, MB; Trefny, MP; Volkmann, K; Vulin, M; Zilli, F; Zippelius, A | 1 |
1 other study(ies) available for acetylcysteine and byl719
| Article | Year |
|---|---|
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer.
Topics: Acetylcysteine; Animals; Breast Neoplasms; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Mice; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases | 2023 |